Rhumbline Advisers CONTINEUM THERAPEUTICS Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Number of Shares
6,042
Previous 6,722
10.12%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%